Research Article
Pulmonary Complications following Cytoreductive Surgery and Perioperative Chemotherapy in 147 Consecutive Patients
Table 2
Demographic and clinical features.
| Patients | | Male | 68 (46%) | Female | 79 (54%) | Age (years) | | Mean standard deviation | 49.9 (8.7%) | Median | 51 (27%) | Range | 23–64 | Primary cancer diagnosis | | Appendix | 135 (92%) | Colorectal | 12 (8%) | Completeness of cytoreduction | | Complete | 125 (85%) | Incomplete | 22 (15%) | Subphrenic peritonectomy | | Right | 109 (74%) | Right and left | 72 (49%) | Blood products | | None | 39 (26.5%) | 1–3 units | 68 (46.3%) | 4 or more | 40 (27.2%) | Fresh frozen plasma | | None | 80 (54%) | 1–4 units | 51 (34.7%) | 5 or more | 16 (10.9%) | Chemotherapy treatments | | HIPEC | 82 (55.8%) | HIPEC + EPIC | 65 (44.2%) |
|
|